Connect with us

Technology

Body Vision Medical Announces Departure of David Webster as CEO and Appoints Matt Baker as Successor

Published

on

CAMPBELL, Calif., July 2, 2024 /PRNewswire/ — Body Vision Medical, a leader in AI-driven intraoperative image guidance, announced today that David Webster has stepped down as Chief Executive Officer and that the Board of Directors has selected Matt Baker, Body Vision’s current Chief Operating Officer, to succeed Webster as CEO.

During his tenure, Webster oversaw several initiatives that elevated Body Vision’s ability to democratize its AI-driven imaging technology including the expansion of the company’s global footprint from two markets to nearly 50, expansion of strategic engagements, and reorganization of the corporate structure to streamline and focus operations. 

Stepping into the CEO position, Baker has served as Body Vision’s COO for the past two and a half years and has over 30 years of experience in global medical device and healthcare IT industries, making him well-equipped to ensure a seamless transition and continue the company’s aggressive growth trajectory.

“We extend our heartfelt gratitude to David Webster for his exceptional leadership and unwavering dedication during his tenure as CEO,” said Yuval Bar-Gil, Body Vision’s Chairman of the Board. “David’s visionary guidance has put the company in a strong financial and commercial position and we are confident in Matt’s ability to continue the company’s growth and excellence in all aspects during this transitional period and beyond.”

About Body Vision Medical

Body Vision Medical believes in saving lives through the democratization of innovative medical technology and the Quintuple Aim is at the heart of everything that we do. Our first commercial product, LungVision®, provides AI-powered real-time image guidance to address the unmet clinical need for early, definitive lung cancer diagnosis and, in the future, to enable effective treatment of lung lesions via a minimally invasive procedure.

Visit bodyvisionmedical.com to learn more and connect with us on LinkedIn.

Contact:

Victor Chan
+1.415.794.1053
info@bodyvisionemedical.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/body-vision-medical-announces-departure-of-david-webster-as-ceo-and-appoints-matt-baker-as-successor-302187445.html

SOURCE Body Vision Medical

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

LOWE’S INVITES BAY AREA RESIDENTS TO “TRY ON” THEIR KITCHEN WITH LOWE’S STYLE STUDIO™

Published

on

By

Designed exclusively for Apple Vision Pro, Lowe’s Style Studio™ empowers customers to visualize and experience a kitchen refresh in minutes at five Bay Area stores starting April 26

CHARLOTTE, N.C., April 25, 2025 /PRNewswire/ — Beginning Saturday, April 26, Lowe’s stores in northern California will offer free appointments for Lowe’s Style Studio™, an immersive 3D experience that lets customers design and “try on” their dream kitchen using Apple Vision Pro, changing the colors, styles, and features around them in real time. Lowe’s Style Studio™ combines spatial computing with home improvement, giving customers the ultimate confidence of experiencing their dream kitchen—or a smaller project like a new sink or wall color —before actually renovating it.

“We try on clothes, sample paint colors, and test drive cars to help us decide before we buy,” said Chandhu Nair, Lowe’s SVP of Data, AI and Innovation. “Customers deserve that same confidence when it comes to home renovation. With Lowe’s Style Studio, consumers don’t have to guess what their new kitchen could look like—they can step into it and experience their style choices together as if they are actually there. This is the future of retail—personal, immersive, and powered by technology.”

Lowe’s shoppers can focus on a single aspect of the kitchen—like a new cabinet color—or reimagine the entire room using Lowe’s Style Studio™ for Apple Vision Pro. Within the experience they can view full-sized countertops, backsplashes, and appliances within a kitchen, all for free. This is particularly helpful for products like countertops, where a full scale rendering allows customers to see additional variation and veining. Whether it’s a major overhaul or a small refresh, Lowe’s Style Studio™ makes it easy to explore design possibilities before spending a dime.

The pressure to get kitchen remodels right impacts DIYers and the Pros that support them. Interior designers, real estate agents, and installers have used Lowe’s Style Studio™ to help clients feel more comfortable with their design selections. By turning ideas into immersive, shared experiences, the tool brings everyone to the table with clarity and confidence—and with Lowe’s lowest price guarantee, customers can feel good about their choices from every angle. Spatial computing seamlessly blends digital content into the physical space, enabling users to interact in stunning resolution, using intuitive input controlled by a user’s eyes and hands.

Customers are encouraged to bring family members or home professionals to their session, where they can follow along on an iPad that mirrors the Apple Vision Pro experience. Customers can then digitally save and share their selected styles at the end of the session. These can also be saved to the customer’s Lowes.com account for future reference at home.

Sessions are free with no purchase commitments and available by appointment or walk-in (appointments are preferred). Appointments can be made at Lowes.com for the following California stores:

Concord, 1935 Arnold Industrial Way, ConcordEast San Jose, 775 Ridder Park Dr., San JoseDublin, 3750 Dublin Blvd., DublinSouth San Jose, 5550 Cottle Rd., San JoseSunnyvale, 811 East Arques Ave., Sunnyvale

About Lowe’s
Lowe’s Companies, Inc. (NYSE: LOW) is a FORTUNE® 50 home improvement company serving approximately 16 million customer transactions a week in the United States. With total fiscal year 2024 sales of more than $83 billion, Lowe’s operates over 1,700 home improvement stores and employs approximately 300,000 associates. Based in Mooresville, N.C., Lowe’s supports the communities it serves through programs focused on creating safe, affordable housing, improving community spaces, helping to develop the next generation of skilled trade experts and providing disaster relief to communities in need. For more information, visit Lowes.com.

Media Contact
Caitlin Byrnes
Lowe’s Companies, Inc.
caitlin.byrnes@lowes.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/lowes-invites-bay-area-residents-to-try-on-their-kitchen-with-lowes-style-studio-302438748.html

SOURCE Lowe’s Companies, Inc.

Continue Reading

Technology

Zepp Health Corporation Files 2024 Annual Report on Form 20-F

Published

on

By

MILPITAS, Calif., April 25, 2025 /PRNewswire/ — Zepp Health Corporation (“Zepp Health” or the “Company”) (NYSE: ZEPP), a global leader in smart wearables and health technology, today announced that it has filed its annual report on Form 20-F for the full year ended December 31, 2024 with the U.S. Securities and Exchange Commission (the “SEC”).

The annual report can be accessed on the Company’s investor relations website at http://ir.zepp.com and on the SEC’s website at www.sec.gov. The Company will provide hardcopies of the annual report, free of charge, to its shareholders and ADS holders upon request. Requests should be submitted to ir@zepp.com.

About Zepp Health Corporation (NYSE: ZEPP)

Zepp Health Corporation (NYSE: ZEPP) is a global smart wearable and health technology leader, empowering users to live their healthiest lives by optimizing their health, fitness, and wellness journeys through its leading consumer brands, Amazfit, Zepp Clarity and Zepp Aura. Powered by its proprietary Zepp Digital Management Platform, which includes the Zepp OS, AI chips, biometric sensors and data algorithms, Zepp delivers cloud-based 24/7 actionable insights and guidance to help users attain their wellness goals. To date, Zepp has shipped over 200 million units, and its products are available in more than 90 countries and regions. Founded in 2013 as Huami Corp., the Company changed its name to Zepp Health Corporation in February 2021 to emphasize its health focus with a name that resonates across languages and cultures globally. Zepp has team members and offices across globe, especially in Europe and USA regions.

For investor and media inquiries, please contact:

In China:
Zepp Health Corporation
Grace Yujia Zhang
Email: ir@zepp.com 

Piacente Financial Communications
Tel: +86-10-6508-0677
Email: zepp@tpg-ir.com 

 

View original content:https://www.prnewswire.com/news-releases/zepp-health-corporation-files-2024-annual-report-on-form-20-f-302438423.html

SOURCE Zepp Health Corp.

Continue Reading

Technology

Symphony Robotics Welcomes Neurosurgery Leader Dr. Neil A. Martin as Chief Medical Officer to Revolutionize Glioblastoma Treatment with First-Ever MRI-Steerable Micro-Robotics

Published

on

By

MIAMI, April 25, 2025 /PRNewswire/ — Symphony Robotics, a pioneer in advanced neurosurgical micro-robotics, today announced the appointment of renowned neurosurgeon Dr. Neil A. Martin as its Chief Medical Officer (CMO). In this pivotal role, Dr. Martin will lead the advancement of the company’s groundbreaking, engine-free, nonlinear, flexible micro-robotic system, poised to transform the treatment landscape for Glioblastoma Multiforme (GBM).

Symphony Robotics, a pioneer in advanced neurosurgical micro-robotics, appoints renowned neurosurgeon as CMO.

“Glioblastoma remains the most treatment-resistant and lethal primary brain tumor, with a median survival of only 14-16 months following maximal safe resection plus adjuvant chemoradiotherapy, and a five-year survival rate below 7%,” stated Dr. Martin. “Despite significant advances in molecular characterization and targeted therapeutics, meaningful improvements in clinical outcomes have remained elusive.”

Early preclinical studies using anatomically accurate GBM models under real-time MRI guidance have shown that Symphony Robotics’ platform achieves significant improvements in maneuverability, resulting in up to 3 times the volumetric coverage when compared with existing technologies, with millimeter-level precision, crucial for protecting critical healthy brain tissue while maximizing tumor removal.

Dr. Martin continued, “Symphony Robotics is positioned to transform the treatment paradigm by substantially extending the capabilities of Laser Interstitial Thermal Therapy (LITT) in GBM—potentially tripling the ablation volume achievable through its steerability after single-site minimally invasive insertion. Our initial objective is to significantly enhance the efficacy of LITT through precise, nonlinear navigation to previously unreachable tumor margins, even in large and irregular tumors. We are implementing an aggressive translational research pipeline for developing applications to accompany and synergize with thermal ablation, including targeted drug and immunotherapy delivery systems for precision neuro-oncology.”

“Symphony Robotics is built on a foundation of rigorous research and a robust intellectual property portfolio, supported by grants from the National Institutes of Health (NIH) and the National Science Foundation (NSF), and exclusively licensed from Case Western Reserve University,” said Mordechai (Moty) Avisar, Founder and CEO of Symphony Robotics. “Welcoming Dr. Martin—a visionary leader in neurosurgery—to our team marks a pivotal milestone that will accelerate our mission to revolutionize GBM treatment. By harnessing the power of artificial intelligence, our platform is poised to optimize therapy and deliver this life-changing technology to patients worldwide.”

The company is currently establishing collaborations with leading neurosurgical centers to initiate beta site testing later this year, ensuring thorough clinical assessment in diverse patient populations and anatomical scenarios.

CONTACT: info@symphonyrobotics.health
LinkedIn: https://www.linkedin.com/company/symphonyrobotics/

Symphony Robotics is developing advanced medical technology focused on transforming neurosurgical precision through its engine-free, nonlinear, flexible, micro-robotic platform, leveraging AI to optimize GBM treatment. Recognizing the limitations of current techniques in treating complex intracranial pathologies, particularly aggressive cancers like GBM and medically refractory epilepsy, the company aims to improve surgical outcomes by enabling more precise and extensive tumor ablation, minimizing damage to healthy brain tissue, and ultimately improving both patient survival and quality of life. The integration of real-time MRI guidance with advanced robotics and computational navigation algorithms allows their innovative platform to access and treat previously unreachable areas within the brain. Disclaimer: Symphony Robotics’ products are not approved by the Food and Drug Administration (FDA) and are not available for commercial distribution or clinical use.

View original content to download multimedia:https://www.prnewswire.com/news-releases/symphony-robotics-welcomes-neurosurgery-leader-dr-neil-a-martin-as-chief-medical-officer-to-revolutionize-glioblastoma-treatment-with-first-ever-mri-steerable-micro-robotics-302438762.html

SOURCE Symphony Robotics

Continue Reading

Trending